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Abstract
Chelt, a cholera-like toxin from Vibrio cholerae, and Certhrax, an anthrax-like toxin from Bacillus cereus, are among six new
bacterial protein toxins we identified and characterized using in silico and cell-based techniques. We also uncovered
medically relevant toxins from Mycobacterium avium and Enterococcus faecalis. We found agriculturally relevant toxins in
Photorhabdus luminescens and Vibrio splendidus. These toxins belong to the ADP-ribosyltransferase family that has
conserved structure despite low sequence identity. Therefore, our search for new toxins combined fold recognition with
rules for filtering sequences – including a primary sequence pattern – to reduce reliance on sequence identity and identify
toxins using structure. We used computers to build models and analyzed each new toxin to understand features including:
structure, secretion, cell entry, activation, NAD
+ substrate binding, intracellular target binding and the reaction mechanism.
We confirmed activity using a yeast growth test. In this era where an expanding protein structure library complements
abundant protein sequence data – and we need high-throughput validation – our approach provides insight into the
newest toxin ADP-ribosyltransferases.
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Introduction
Sequence data from over 6,500 genome projects is available
through the Genomes OnLine Database [1] and more than
60,000 protein structures are in the Protein Data Bank (PDB).
While these sequences represent large diversity, a limited number
of possible folds – estimated at 1,700 [2] – helps researchers
organize the sequences by structure. A single fold performs a
limited number of functions, between 1.2 and 1.8 on average [3].
Therefore, structure knowledge helps pinpoint function. Research-
ers are combining sequence and structure data to expand protein
families such as the mono-ADP-ribosyltransferase (mART) protein
toxins that participate in human diseases including diphtheria,
cholera and whooping cough [4].
ADP-ribosylation is a post-translational modification that plays
a role in many settings [5]. ADP-ribosyltransferases (ADPRTs)
bind NAD
+ and covalently transfer a single or poly ADP-ribose to
a macromolecule target, usually protein, changing its activity.
Many prokaryotic ADPRT toxins damage host cells by mono-
ADP-ribosylating intracellular targets. G-proteins are common
targets including: eukaryotic elongation factor 2 (ADP-ribosylation
halts protein synthesis), elongation factor thermo unstable, Ras,
Rho (ADP-ribosylation locks Rho GTPase in the GDP-bound
state and disaggregates the actin cytoskeleton) and Gs-a (ADP-
ribosylation interrupts signal transduction). Other targets include
actin (ADP-ribosylation inhibits actin polymerization) [6]; kinase
regulators (ADP-ribosylation inhibits phagocytosis) [7] and RNA-
recognition motifs (ADP-ribosylation alters the transcriptome and
weakens immunity) [8].
Researchers use ADPRT toxins to develop vaccines [9], as drug
targets, to kill cancer cells [10], as stent coatings to prevent
restenosis after angioplasty [11], as insecticides, to deliver foreign
proteins into cells using toxin receptor-binding and membrane
translocation domains, to study cell biology [12,13], to understand
the ADP-ribosylation reaction and to identify biosecurity risks.
ADPRTs occur in viruses, prokaryotes, archaea and eukaryotes.
Genomes acquire them through horizontal gene transfer [14–17].
Several authors have reviewed the prokaryotic ADPRT family
[6,18,19]. Examples include Pseudomonas aeruginosa exoenzyme S
(ExoS), Vibrio cholerae cholera toxin (CT), Bordetella pertussis pertussis
toxin (PT) and Corynebacterium diphtheriae diphtheria toxin (DT).
Toxic ADPRTs are divided into the CT and DT groups to better
organize the family. We focus on the CT group, which we divide
into the ExoS-like, C2-like, C3-like and CT-PT-like toxins.
CT group primary sequences are related through a specific
structure-linked pattern (Figures 1 and 2) [20]. The ADPRT
pattern, updated from previous reports [4,21] and written as a
regular expression is:
YFL ½  -R-X 27,60 ðÞ - YF ½  -X-S-T- SQT ½  -X 32,78 ðÞ - QE ½  -X-E
The toxin catalytic domain consists of several regions. We
describe them here going from the N- to C-terminus using
previously introduced nomenclature [20,22]. Region A (not
shown) is sometimes present and recognizes substrate, when ExoT
recognizes Crk, for example. Its recognition of ExoT targets is an
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CT-PT-like subgroup, region B – an active site loop flanked by
two helices – appears early in the toxin sequence. It stabilizes the
‘‘catalytic’’ Glu, binds the nicotinamide ribose (N-ribose) and the
adenine phosphate (A-phosphate). It also stabilizes the target
substrate and helps specific bonds rotate during the ADPRT
reaction, in turn, helping to bring the nucleophile and electrophile
together for reaction. (The CT-PT-like subgroup lacks region B
and instead has a knob region that precedes region 2; these might
function interchangeably.) Region 1 is at the end of a b-sheet, with
sequence pattern [YFL]RX. It is important for binding A-
phosphate, nicotinamide phosphate (N-phosphate), nicotinamide,
adenine ribose (A-ribose) and the target substrate. Region F (not
shown) follows region 1 and sometimes recognizes substrate. The
region 2 (STS motif) follows on a b-sheet with sequence pattern
[YF]-X-S-T-[SQT]. It binds adenine, positions the ‘‘catalytic’’
Glu, orients the ADP-ribosyl-turn-turn (ARTT) loop and main-
tains active site integrity. The phosphate-nicotinamide (PN) loop
(also known as region E) is immediately after the STS motif. It
interacts with the target and binds N-phosphate. Menetrey et al.
suggested the PN loop is flexible and implicated it in locking the
nicotinamide in place during the reaction [23]. Region 3 (also
known as region C) consists of the ARTT loop leading into the b-
sheet with pattern [QE]-X-E. It recognizes and stabilizes the
target and binds the N-ribose to create a strained NAD
+
conformation. The ARTT loop is plastic, having both ‘‘in’’ and
‘‘out’’ forms that might aid substrate recognition [23]. The FAS
region (also known as region D, not shown) mediates activator
binding when present [6,22,24,25].
Researchers have long debated the ADPRT reaction details.
Some suggest an SN2 mechanism [26,27], but many now favor the
SN1 mechanism [28–32]. Tsuge et al. recently devised a specific
version of this mechanism for iota toxin, which we follow closely in
this work [33,34]. The reaction follows three steps: the toxin
cleaves nicotinamide to form an oxacarbenium ion, the oxacarbe-
nium O5D-PN bond rotates to relieve strain and forms a second
ionic intermediate. (The electrophile and nucleophile might
migrate by an unknown mechanism to further reduce the distance
between them.) Finally, the target makes a nucleophilic attack on
the second ionic intermediate. The SN1mechansim – believed
widely applicable to CT group toxins – is a template for new toxins
given the historical structure similarity and consistent NAD
+
conformation in the active site as shown in Figures 1 and 2.
Quaternary structure for the toxins is wide-ranging. Several
combinations exist for toxin domains (A) and receptor binding or
membrane translocation domains (B). The B domains have diverse
structures and functions and exist as fusions or separate
polypeptides. Various formats include: A-only, two-domain AB
(single polypeptide), three-domain AB (single polypeptide) and
AB5 (multiple polypeptides). C3-like toxins are A-only. ExoS-like
toxins have toxic A-domains and are often paired with Rho
GTPase activating protein (RhoGAP), which are not true B
domains. C2-like toxins are AB toxins that contain B domains that
are structural duplicates of the A domain. These B domains are
not toxins; they bind proteins that are similar to anthrax protective
antigen (PA) including Vip1, C2-II and Iota Ib [35,36]. DT group
toxins are three-domain, single polypeptide AB toxins where the B
domain contains both a receptor-binding and a membrane-
translocation domain. The CT-PT-like toxins are AB5 and have B
domains that form a receptor-binding pentamer [37].
Low overall sequence identity hampers conventional sequence-
based homology searches [17,20,38–40]. One challenge – key to
filling gaps in the toxin family – is to link new sequences and
known toxins. Depending only on amino acid sequence alignment
techniques to discover new toxins is imprudent. Instead the trend
is to use more structure information in the search because many
primary sequences produce the same fold [41]. Researchers can
then link these sequences through fold recognition [42].
Otto et al. used PSI-BLAST to identify new ADPRT toxins,
including SpvB from Salmonella enterica [14]. More recently a
similar strategy yielded 20 potential new toxins [15]. This led to
interesting examples later characterized including: CARDS toxin
from Mycoplasma pneumonia [43], SpyA from Streptococcus pyogenes
[44] and HopU1 from Pseudomonas syringae [8].
PSI-BLAST is a classic way to expand protein families, but it has
limits. For example, unrelated sequences often ‘‘capture’’ the search.
Also, nearly a decade has passed since Pallen et al. released the last
detailed data mining results for the toxin family [15]. The sequence
and structure databases – and remote homolog detection tools – have
advanced during this time. Masignani et al. proposed that a match
between the conserved ADPRT pattern with corresponding
secondary structure is one way to reduce dependence on sequence
identity. The pattern helps ensure function and reduces the total
sequence set to a smaller subset for screening; secondary structure
prediction ensures that key active site parts are present [17].
Our contribution is to expand ADPRT toxin family using a new
approach. The difference is that we use fold-recognition searches
extensively rather than relying on PSI-BLAST or secondary
structure prediction. Our genomic data mining combines pattern-
and structure-based searches. A bioinformatics toolset allows us to
discover new toxins, classify and rank them and assess their
structure and function. Often, data mining studies simply present a
table of hits with aligned sequences, but do not interpret or analyze
those hits in detail. Our aim – rather than to explicitly confirm the
roles of the six proteins, 15 domains, 18 loops and 120+ residues
discussed – is to develop a theoretical framework for understand-
ing new toxins, based on 100s–1000s of jobs per sequence. We
intend our in silico approach to guide and complement – rather
than replace – follow-up in vitro and in vivo studies. Here, we extract
features and patterns from known ADPRT toxins and explain how
they fit new toxins. We use in silico methods to probe structure,
secretion, cell entry, activation, NAD
+ substrate binding, intracel-
lular target binding and reaction mechanism.
A computer approach is fitting for several reasons. Such an
environment is a safe way to study new toxins. Challenges in
cloning, expressing, purifying and crystallizing often prevent in vitro
characterization. Also, ADPRTs are abundant within bacterial
genomes and researchers make the sequences available faster than
we can conduct biochemical studies. New toxins might play a role
in current outbreaks and are also excellent drug targets against
antibiotic resistance. Our new study design expands the family by
,15% (from 36 to 42 toxins).
Cell-based validation complements our in silico approach. We
use Saccharomyces cerevisiae as a model host to study toxin effects.
Author Summary
Computer tools helped us uncover and understand potent
protein toxins that empower bacterial pathogens against
plants, animals and man. These toxins are potential drug
targets and researchers can use them to make vaccines.
New toxin knowledge aids the long-term goal of finding
alternatives to antibiotics, to which pathogens are
becoming more resistant. The toxins share similar structure
despite low sequence identity, so our search links
sequence and structure features. We present a ranked list
and computational characterization of six new toxins
combined with cell-based tests.
Characterization of Bacterial Toxins
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toxins. Yeast are easy to grow, have well-characterized genetics
and are conserved with mammals in cellular processes including:
DNA and RNA metabolism, signalling, cytoskeletal dynamics,
vesicle trafficking, cell cycle control and programmed cell death
[45–47]. We place the toxin genes under the control of a copper-
inducible promoter to test putative toxins for ADP-ribosyltransfer-
ase activity in live cells [48]. A growth-defective phenotype clearly
shows toxicity. Substitutions to catalytic signature residues
confirms ADP-ribosyltransferase activity causes the toxicity.
Indeed, pairing in silico and cell-based studies helps identify and
characterize new ADPRT toxins.
Results/Discussion
Data mining for new ADPRT toxins
We searched fold-recognition databases – including Pfam 24.0
[49], Gene3D 9.1.0 [50] and SUPERFAMILY 1.73 [51] – using
SCOP and CATH codes of known toxins. These strategies relate
sequences with profiles. We also used a sensitive profile-profile
based search strategy, HHsenser 2.13.5 [52]. We combined the
results from our various searches and filtered them by successively
applying exclusions to discover new ADPRT toxins. First, we had
2106 hits. We kept only bacterial hits (lost 1222) from pathogens
(lost 445) that tested positive for secretion (lost 95), had the
conserved ADPRT pattern (lost 218) and had less than 50%
identity to a known toxin (lost 87). This left 39 hits. We reduced
them to 29 by clustering at the 50% identity level. We removed
one more sequence on the basis of genetic context (a hydrolase
gene was next to the toxin gene, suggesting possible de-ADP-
ribosylation reactions). This left 28 sequences. Of these, we found
15 from Pfam, Gene3D and HHsenser; eight from both Gene3D
and HHsenser; four from HHsenser only; and one from both Pfam
and Gene3D. We chose five of the 28 sequences to analyze more
thoroughly. We also present our analysis of TccC5, a toxin we
previously proposed [4] that Lang et al. biochemically character-
ized during this writing [53].
We count 36 known ADPRT toxins (see [4] for a recent table
and note that researchers recently characterized several [54–57]).
The six described in this writing bring the total to 42 distinct
ADPRT toxins that generally have identity ,50% unless the
species or domain organization is different. We may want to
remove the pattern constraint in the future and further expand the
toxin pattern. Here, we prefer higher accuracy at the risk of
removing some true ADPRT toxins from our list. Five of the six
toxins described appear in a simple protein-protein BLAST
search. But identity is typically low enough that many false hits
appear as well. This makes the simple BLAST search ineffective.
Randomly created sequences, for example, regularly return
BLAST hits at ,25% identity. (For example, we tried 10 BLAST
searches using 200-residue random sequences with average Swiss-
Prot amino acid composition. We received top hits of average
length 99 and having 29% identity to a natural protein.)
We ranked the toxin candidates by relevance signalled by ISI
Web of Knowledge hits to the species name (Table 1). As well, we
list the fold prediction strength given by J3D-jury and catalytic
domain novelty suggested by sequence identity to the nearest
known toxin. 3D-jury accepts models from various servers and
makes pair-wise comparisons. Each pair gets a similarity score that
equals the total number of Ca atom pairs within 3.5A ˚ after
overlap. The final score is the sum of the similarity scores divided
by the number of pairs considered plus one. A higher J3D-jury
implies a stronger prediction. The closest toxin relative to a newly
predicted toxin indicates the new toxin’s novelty and aids function
prediction. Identity to a known toxin ranges from 25% to 60%.
We show predictions for the toxins in Table 2.
Aligned sequences of known and new CT group toxins are
critical to further studies (Figures S1 and S2 in Text S1). We
removed positions with gaps and represented the alignment in
LOGO format for the ExoS-like, C2-like, C3-like subgroups
(Figure 1) and the CT-PT-like subgroup (Figure 2). Also, we
correlated critical residues with previous X-ray structures and
function information. We used an alignment that contained all CT
group toxins to build a phylogenetic tree that groups known and
new toxins into subgroups, shown in Figure 3. We use this tree to
show relationships between the toxins independent of any specific
evolutionary pathway. Such a pathway is difficult or impossible to
deduce because of horizontal, rather than vertical, gene transfer.
We did not include eukaryotic ARTs in our tree because they are
not within this paper’s scope. But, they often group well with C3-
like toxins, and many eukaryotic PARPs group with the DT group
toxins. Also, we calculated a pair-wise identity matrix (Table S1 in
Text S1), revealing identity between known and new CT group
toxins. We invite readers to skip to the species or toxin of most
interest; each one is described independently.
V. cholerae Chelt: A new cholera toxin with likely different
cell-entry machinery
V. cholerae produces cholera and cholix toxins [4]. Chelt
(UniProt A2PU44) is, to our knowledge, the third ADPRT toxin
identified in V. cholerae, the bacterium responsible for cholera
outbreaks and food poisoning. The genome sequence of V. cholerae
strain MZO-3 serogroup O37, isolated from a patient in
Bangladesh (Heidelberg, J. and Sebastian, Y., 2007, Annotation
of Vibrio cholerae MZO-3, TIGR) encodes Chelt. It is specific to this
strain. Chelt GC content is 14% lower than the overall genome
(34% vs. 48%); also, a transposase gene immediately follows the
Chelt gene, indicating horizontal gene transfer typical of the
ADPRT toxins. Chelt is a 601-residue, 69 kDa protein. It has a
secretion signal (,1–18), followed by toxin domain Ia (,19–179)
and Ib (,180–240) and a presumed cell-binding domain II
(,241–601) (Figures 4A and 5A).
Chelt is unusual in that it has a second domain attached to the
catalytic domain (Figure S3 in Text S1). Because the genome does
not obviously encode a B-domain pentamer, domain II could fulfill
that role. After secretion, Chelt likely uses it to bind to the cell
surface. Domain II has significant structure similarity to Psathyrella
velutina lectin (PDB 2BWR; 15% identity; J3d-jury=152; an easy
target for the Local Meta-Threading-Server LOMETS, which
provides this high-confidence match). Weaker similarities also exist
to human integrin aVb3 (PDB 2VDR; 11% identity; an easy
target for LOMETS, which provides this high-confidence match).
Figure 1. Sequence-structure-function relationships in ExoS-like, C2-like and C3-like toxins. (A) The curated sequence alignment
presented in LOGO-format. The largest residues are important for catalysis and perhaps also folding. Difficult-to-read text is unimportant. (B) Multiple
structure alignment of the active site showing structural position of the conserved residues. PDB IDs: Iota (1GIQ), Art2.2 (1OG3), C3stau2 (1OJZ), Vip2
(1QS1), C3bot2 (1R45), C3bot1 (2A9K), SpvB (2GWL), C2-I (2J3X), CdtA (2WN7), C3lim (3BW8). Important residues have a relatively constant position.
NAD
+ position is more variable toward the adenine end of the dinucleotide. (C) Functional relevance of active site residues [6]. Numbers not listed
imply a role not yet assigned.
doi:10.1371/journal.pcbi.1001029.g001
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Indeed bacterial lectins can mimic eukaryotic adhesion motifs
[58]. Structurally, the domain is a seven-bladed b-propeller
(SCOP b.69.8, CATH 2.130.10), with each blade containing seven
four-stranded b-sheet motifs that meander. The lectin suggests a
role in sugar and Ca
2+, or possibly Mg
2+, binding and perhaps
even integrin mimicry. Chelt is reminiscent of ricin toxin from the
castor bean. Ricin is a two-domain toxin that contains both a
lectin for binding the cell-surface galactosyl residues for cell-entry
and a second domain that causes cell death [59].
Domain I, the catalytic domain, is 60% identical to LT-A from
Escherichia coli. This toxin clearly fits into the Gas–targeting CT-
PT-like subgroup because sequence identity to LT-A is so high.
Fold recognition returned a match to LT-A (PDB 1LT4, J3D-
jury=178) and our model against this template was also high
quality. The Chelt catalytic domain adopts an a+b ADP-
ribosylation fold consisting of anti-parallel b-sheets and having
separate a and b regions.
Chelt must likely be activated by reduction of a disulfide bond
between Chelt C205 and C220; cleavage at or near I215 (details
are unclear due to a four amino acid deletion compared to LT-A
between H214 and I215); and interaction with an ADP-
ribosylating factor, perhaps ARF3, in the Chelt regions ,45–57,
,109–113, ,134–141 and ,167–182 (Figure S3 in Text S1).
We propose a likely mode of NAD
+ binding, target binding and
ADP-ribosylation based on alignment data and our modeling
experiments. Once activated, Chelt binds NAD
+ through
hydrogen bonds, hydrophobic interactions and aromatic interac-
tions (Figure 6A, Figure S4 in Text S1, Table 3). We propose these
H-bonds: Y41 binds to adenine, S28 binds to A-ribose, R43 binds
to A-phosphate, R25 binds to A- or N-phosphate, E130 binds to
N-ribose and A26 binds to nicotinamide. Chelt recognizes Gas
using the knob (,66–71), the a3 helical region (,82–99) and the
ARTT loop (,104–129) (Table 4). The ARTT loop might
plastically rearrange between the in and out conformation during
this process. Anchor residues S123 and Q127 in the second part of
the loop may act as hinges to reposition H125 to interact with Gas.
We propose an SN1 alleviated-strain mechanism (Figure 7). First,
E130 H-bonds to the N-ribose while phosphate electrostatic
interactions hold the NAD
+ in a conformation that favors
oxacarbenium ion formation. The reaction’s progress is unclear.
T71 might induce a rotation about the O5D-PN bond of the
oxacarbenium ion to reduce the nucleophile-electrophile distance.
AG as Glu or Asp stabilizes N-ribose, E128 stabilizes Gas R201
and Gas R201 attacks the oxacarbenium ion. Several residues hold
the active site in place including: Chelt S79, which H-bonds to
E130; T80, which stiffens the active site through H-bonding to a
nearby b-sheet and T81, which orients the ARTT loop and E128.
Hydrophobic interactions with NAD
+ involve D27, R29, P42, I90,
I94 and L95. Also, H62 stabilizes E130.
Cell-based toxin expression in yeast, driven by the copper-
inducible CUP1 promoter, shows cell death in the presence of the
wild-type toxin. We observed mild growth restoration with the
E128A mutant, dramatic growth restoration with the E130A
mutant and near-complete growth restoration with the E128A/
E130A double mutant (Figure 8A). The wildtype growth-defective
phenotype clearly shows Chelt toxicity. Substitutions to E128 and
E130 confirm that this toxicity is because of Chelt ADP-
ribosyltransferase activity. Researches may modify Chelt in the
future with the E128A and E130A substitutions – or produce
recombinant forms including domain II only – to make vaccines
similar to the commercial Dukoral [60].
B. cereus Certhrax: Anthrax toxin with a different cell-
killing strategy
Certhrax (UniProt Q4MV79) is encoded in B. cereus G9241. (A
slightly larger relative exists in another B. cereus strain.) Most B.
cereus strains are harmless or cause foodborne illness, but
researchers have implicated this strain in several severe pneumonia
cases [61–63]. Certhrax, a 476-residue, 55 kDa protein, is the first
anthrax-related ADPRT toxin to our knowledge. It is 31%
identical to lethal factor from Bacillus anthracis. The closest fold
recognition match is to anthrax toxin lethal factor (LF, PDB 1J7N;
J3D-jury=239, a high score reflecting a two-domain match). So we
Figure 2. Sequence-structure-function relationships in CT-PT-like toxins. (A) The curated sequence alignment presented in LOGO-format.
The largest residues are important for catalysis and perhaps also folding. Difficult-to-read text is unimportant. (B) Multiple structure alignment of the
active site showing structure conservation of these residues. PDB IDs: CT (1S5D), LT-IIB (1TII), LT-A (1LTS), PT (1BCP), CT (2A5F). Little variation exists in
important residue positions. (C) Functional relevance of active site residues [6]. Numbers not listed imply a role not yet assigned.
doi:10.1371/journal.pcbi.1001029.g002
Table 1. New ADPRT toxin ranking.
Rank Name Species Accession Interest I
a J
b Structure match N
c
Sequence
match
1 Chelt V. cholerae MZO-3 A2PU44 Cholera, food poisoning 12,458 178.12 LT-A (1LT4) 60 LT-IIA, LTII-B
2 Certhrax B. cereus G9241
[269801]
Q4MV79 Inhalation anthrax, food poisoning 11,529 217.25 Anthrax lethal factor
(1J7N)
34 CdtA
3 Mav toxin M. avium (strain 104) A0QLI5 Respiratory infection, tuberculosis-
like pulmonary infection
11,289 125.75 C3bot1 (2BOV) 30 HopU1, AexT
4 EFV toxin E. faecalis Q838U8 Urinary infection, bacteremia,
endocarditis
10,422 158.12 C2-I (2J3Z) 29 C3lim
5 TccC5 P. luminescens
(laumondii)
Q7N7Y7 Toxemia, septicaemia 556 49 C3bot2 (1R45) 25 SpvB
6 Vis toxin V. splendidus 12B01 A3UNN4 Vibriosis 241 129.4 Iota (1GIQ) 28 C2-I, HopU1
aI=ISI Web of Knowledge hits to species name.
bJ=J-score from 3D-jury consensus fold recognition.
cN=percent identity (catalytic core) to known ADPRT.
doi:10.1371/journal.pcbi.1001029.t001
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I( ,1–241) presumed to bind PA and domain II (,242–476) is the
toxin domain (Figures 4B and 5B).
B. cereus cells secrete this protein non-classically. Certhrax likely
behaves similarly to LF in cell entry because of similarities in
domain I, which is likely responsible for PA-binding. We describe
a supposed model of Certhrax here using LF as a template [64].
Under harsh conditions, B. cereus forms spores that humans inhale
into lung alveoli. Spores that escape from macrophages enter the
lymph system where B. cereus germinates. Here, B. cereus produces
protective antigen (PA, UniProt Q4MV80) that may bind
Certhrax and edema factor (UniProt Q4MKW0). Both Certhrax
and LF have a PA binding domain; sequence identity over this
domain is 36%, within the safe zone of homology. But, Certhrax
lacks the catalytic zinc metalloprotease domain of LF that
proteolyzes mitogen activated protein kinase kinase (MAPKK or
MEK). It contains a functional ADPRT domain instead of the
vestigial ADPRT domain of LF (Figure S5 in Text S1). PA likely
binds to ANTXR1/2 or LRP6 receptor. Furin proteolyzes PA so a
PA heptamer can form. Certhrax and edema factor bind the PA
heptamer and are translocated into the cell in a clathrin-coated pit.
Low pH in the endosome causes a pore to form through which
Certhrax and EF travel and enter the cytosol [64].
Domain II matches to iota toxin (PDB 1GIQ, J3D-jury=143).
Fold recognition and phylogenetic analysis suggest similarities to
C3-like toxins. We propose a likely mode of NAD
+ binding, target
binding and ADP-ribosylation based on alignment data and our
modeling experiments (Figure 6B, Figure S4 in Text S1, Table 3).
These H-bonds are likely: Q382 and N384 may bind to adenine,
S344 binds to A-ribose, N288 and R292 bind to A-phosphate,
R341 binds to A- or N-phosphate, T280 and E431 bind to N-
ribose and R342 binds to nicotinamide. Active site residue Y398 in
the flexible PN loop locks nicotinamide in the enzyme cleft during
the reaction.
Certhrax likely recognizes its target through the region B active
site loop (,295–314), the PN loop (,390–402) and the ARTT
loop (,420–430) (Table 4). The ARTT loop might plastically
rearrange between the in and out conformation during target
recognition. The second part may hinge on anchor residues S424
and Q429 to reposition Y426 to interact with the target substrate.
We propose the reaction follows an SN1 alleviated-strain
mechanism (Figure 7). First, E431 H-bonds to the N-ribose while
phosphate electrostatic interactions hold the NAD
+ in a confor-
mation that favors oxacarbenium ion formation. Then Y284
induces a rotation about O5D-PN bond of the oxacarbenium ion
that reduces the nucleophile-electrophile distance. Finally, a target
Glu or Asp stabilizes the N-ribose, Q429 stabilizes the target Asn
or Gln and the target Asn or Gln attacks the oxacarbenium ion.
Several residues hold the active site in place including: S387,
which H-bonds to E431; T388, which stiffens the active site
through H-bonding to a nearby b-sheet and S389, which orients
the ARTT loop and Q429. Another conserved residue is Y279,
which may participate in the reaction.
Toxin gene expression in yeast, driven by the CUP1 promoter,
shows cell death in the presence of the wild-type toxin. We
observed mild growth restoration with the Q429A and E431A
mutants and near-complete growth restoration with the Q429A/
E431A double mutant (Figure 8B). The wildtype growth-defective
phenotype clearly suggests Certhrax toxicity. Substitutions to
Q429 and E431 confirm that this toxicity is because of Certhrax
ADP-ribosyltransferase activity. Researchers may eventually
modify Certhrax with the Q429A and E431A substitutions – or
produce recombinant forms of the toxin that include only the PA-
binding domain I – to create vaccines similar to Biothrax that
protects against B. antracis effects [65].
M. avium Mav toxin: A possible type-VII secreted toxin
may matter to AIDS patients
Mav toxin (UniProt A0QLI5) from M. avium strain 104 is a
predicted ADPRT with possible relevance to AIDS patients who
face a high risk of M. avium infections [66]. (Slightly larger relatives
exist in M. avium subsp. paratuberculosis and M. avium subsp.
avium ATCC 25291.) M. avium is both an environmental microbe
and opportunistic pathogen causing chronic, pulmonary infections
in immune-compromised individuals. Mav toxin is an 825-residue,
83 kDa protein with four putative domains: an ESAT6-like
domain I (,1–96), a predicted helical pore-forming domain II
(,97–439), a largely disordered domain III (,440–674) and the
toxin domain IV (,675–825) (Figures 4C and 5C).
Domain I suggests secretion through the ESX (type VII)
secretion system. This matches the non-classical secretion result.
Fold recognition matches residues 1–95 to the 6 kDa early
secreted antigenic target (ESAT-6; PDB 1WA8; J3d-jury=65; 16%
identity). Virulent mycobacteria need the ESX secretion system
for pathogenesis: ESX-1 deletion weakens virulence in M.
tuberculosis, M. bovis and M. marinum [67]. ESAT-6 forms a
heterodimer with the 10 kDa culture filtrate protein (CFP-10).
Researchers believe the tight dimer binds an Rv3871-like ATPase
Table 2. New ADPRT toxin features.
Name Length Domains
a Secretion
b Psoluble
c Crystallization
d Target
e
Chelt 601 Ia (,1–179, toxin); Ib(,180–240); II (,241–601, lectin-like) SP (18|19) 0.141 Amenable Gas R201
Certhrax 476 I (,1–241, PA binding); II (,242–476, toxin) 0.706 0.519 High scoring Asn, Gln or Cys?
Mav toxin 825 I (,1–96, ESAT6); II (,97–439, pore forming?);
III (,440–675, disordered); IV (,675–825, toxin)
0.822 0.332 Recalcitrant Arg?
EFV toxin 487 I (,1–309, needle/pore forming?); II (,310–487, toxin) 0.731 0.258 Recalcitrant Arg?
TccC5 938 I (,1–341, b-propeller); II (,342–675, b-propeller);
III (,676–738, helical); IV (,739–938, toxin)
0.936 0.599 Amenable RhoA Q61
Vis toxin 249 I (1–249, toxin) SP (18|19) 0.611 Amenable Arg?
aPredicted by DOMAC, Ginzu or sliding-window fold recognition.
bSecretomeP scores .0.5 suggest secretion without specific signal peptide; ‘‘SP’’ indicates secretion signal peptide detected by SignalP.
cProbability of solubility by PROSO.
dParCrys crystallization propensity.
eExpected target amino acid (refer to main text for more information).
doi:10.1371/journal.pcbi.1001029.t002
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Rv3870-like protein [68].
Domain II is a-helical, especially from 134–348. It might be a
multi-helical bundle of short and long helices poised to form pores
for target cell entry. Fold recognition matches are to the soluble
domain of bacterial chemoreceptors (PDB 3G67, J3d-jury=93), a
tropomyosin leucine zipper (PDB 2EFR, J3d-jury=78) and spectrin-
like repeats (PDB 1QUU, J3d-jury=76). Domain III has slight
propensity for forming b-sheets; but it is disordered. Its role is
unknown, but it might recognize and bind cell-surface receptors.
Combining domains II and III we found matches to the Cry
insecticidal a-pore-forming toxins (a hard target for LOMETS,
which provides a high-confidence match to PDB 1CIY).
Domain IV is the catalytic domain. Fold recognition suggests
matches to Art2.2 (PDB 1GXY, J3d-jury=126). Mav, compared
with iota toxin, has an 18-residue deletion after region 1 between
P735 and A736. Also, and possibly affecting targeting, it has a two-
residue PN-loop insertion (S765–S766).
We propose a likely mode of NAD
+ binding, target binding and
ADP-ribosylation based on alignment data and our modeling
experiments. NAD
+ binding (Figure 6C, Figure S4 in Text S1,
Table 3) likely involves these H-bonds: E750 binds to adenine,
N733 and possibly T732 bind to A-ribose, N695 and R699 bind to
A-phosphate, R730 binds to A- or N-phosphate, T687 and E795
bind to N-ribose and G731 binds to nicotinamide. Active site
residue F768 on the flexible PN loop locks the nicotinamide in the
enzyme cleft during the reaction. Mav toxin recognizes its target
using the region B active site loop (,701–705), the PN loop
(,758–771) and the ARTT loop (,784–794) (Table 4). The
ARTT loop might plastically rearrange between the in and out
conformation during this process. The first part of the ARTT loop,
anchored between V784 and V787, is likely less flexible than the
second part. The second part hinges on S788 and E793 to
reposition Y790 to interact with the target substrate. We propose
the reaction follows an SN1 alleviated-strain mechanism (Figure 7).
First, E795 H-bonds to the N-ribose while phosphate electrostatic
interactions hold the NAD
+ in a conformation that favors
oxacarbenium ion formation. Then Y691 induces a rotation
about O5D-PN bond of NAD that reduces the nucleophile-
electrophile distance. Finally, a target Glu or Asp stabilized the N-
ribose, E793 stabilizes the target Arg and the target Arg attacks the
oxacarbenium ion. Several residues hold the active site in place
including: S755, which H-bonds to E795; T756, which stiffens the
active site through H-bonding to a nearby b-sheet and S757,
which orients the ARTT loop and E793. Also, Y686 stabilizes
E795.
Neighbourhood and co-occurrence evidence suggest Mav may
interact with the exported repetitive protein (UniProt A0Q9B3) –
suggested as a virulence factor in Mycobacteria [69] – and several
putative uncharacterized proteins. Cloning problems frustrated
cell-based characterization in yeast. As well, we have several
concerns about this prediction: a characteristic WXG motif is
lacking in domain I and the whole protein is unusually long for
ESX-1 secretion. Perhaps Mav toxin uses a variant of the ESX-1
system (ESX-2 to ESX-5). Also, the genetic context suggests a
haloacid dehalogenase-like hydrolase is encoded nearby, making
de-ribosylation reactions a concern. But, we believe this putative
toxin is worth presenting despite these issues because of its
potential health implications.
E. faecalis EFV toxin: A new toxin from a superbug
EFV toxin (UniProt Q838U8) is a medically relevant ADPRT
candidate from a vancomycin-resistant E. faecalis strain, V583 [70].
This strain produces cytolysin toxin [71] and causes urinary
infection, bacteremia and endocarditis [72]. A slightly smaller
relative exists in Enterococcus faecalis CH188. EFV toxin itself is a
487-residue, 56 kDa protein and has a needle-like helical domain I
(,1–309) and catalytic domain II (,310–487) (Figures 4D and
5D).
The toxin is non-classically secreted (i.e., without a signal
peptide). A type IV secretion system has been identified in E.
faecalis [73], but it is unclear if it mediates EFV toxin secretion.
Genetic context suggests that EFV toxin may more likely travel
through a phage infection conduit to target cells. Neighbourhood,
gene fusion and co-occurrence evidence suggest it may interact
with portal proteins (UniProt Q838U9 and Q833E4), a scaffold
protein (Q838U5), a major tail protein (Q835T7), a Cro/CI
family transcriptional regulator (Q835K8) and several putative
uncharacterized proteins. The phage origin makes it unclear
whether EFV toxin acts mainly against bacterial or eukaryotic
targets.
Figure 3. Phylogenetic tree shows relationships between
toxins. This phylogenetic tree reveals four known CT ADPRT toxin
subgroups: ExoS-like, C2-like (includes the SpvB-like toxins), C3-like and
CT-PT-like (includes cholera and pertussis toxins). We built the tree
using an alignment of all ADPRT toxins and MrBayes, which uses
Bayesian inference and a Markov Chain Monte Carlo hill-climbing
algorithm to arrive at a near-optimal tree [96]. We annotated the
branches with bootstrap values. (CARDS toxin is normally considered
part of the CT-PT-subgroup; it is in an unusual position in this tree.)
doi:10.1371/journal.pcbi.1001029.g003
Characterization of Bacterial Toxins
PLoS Computational Biology | www.ploscompbiol.org 8 December 2010 | Volume 6 | Issue 12 | e1001029Domain I bears large sequence similarity to phage minor head
region from 147–268 that suggests a possible phage origin. The
phage head match is reminiscent of the dual role of Alt in
bacteriophage T4 as both a phage head structure component and
a RNA-polymerase targeting ADPRT [74]. Fold recognition on
domain I suggests matches to spectrin (PDB 1U4Q, J3d-jury=49; a
hard target for LOMETS, which provides this high-confidence
match) and weaker matches to the pore-forming domain of colicin
s4 (PDB 3FEW, J3d-jury=42). Also genetic context suggests
similarities to the bacteriophage P22 needle implicated in cell-
envelope penetration [75].
Domain II is 25% identical to Bacillus thuringiensis VIP2 over 166
residues. EFV toxin has C2-like character based on its phyloge-
netic branching. It also has a region 3 EXE sequence pattern that
suggests an Arg target. Fold recognition suggests that its closest
structure match is to C2-I (PDB 2J3Z, J3D-jury=158).
The efforts of the Midwest Center for Structural Genomics have
failed to produce a structure. We propose a likely mode of NAD
+
binding, target binding and ADP-ribosylation based on alignment
data and our modeling experiments (Figure 6D, Figure S4 in Text
S1, Table 3). These H-bonds are likely: S397, N399 or E400 binds
to A-ribose, N354 and R358 bind to A-phosphate, R394 binds to
A- or N-phosphate, T346 and E463 bind to N-ribose and G395
binds to nicotinamide. Active site residue F426 in the PN loop
locks the nicotinamide in the enzyme cleft during the reaction.
EFV toxin recognizes its target using the region B active site loop
(,361–370), the PN loop (,418–436) and the ARTT loop
(,452–462) (Table 4). The ARTT loop might plastically
rearrange between the in and out conformation during this
process, hinging on S456 and E461. Compared with iota toxin,
and possibly influencing target recognition, EFV toxin has a 22-
residue deletion in region F (between regions 1 and 2) between
A403 and I404. Also possibly influencing targeting, EFV toxin has
a six-residue PN loop insertion (E424–F429). We propose the
reaction follows an SN1 alleviated-strain mechanism (Figure 7).
First, E463 H-bonds to the N-ribose while phosphate electrostatic
interactions hold the NAD
+ in a conformation that favors
oxacarbenium ion formation. Then F350 likely induces a rotation
about the O5D-PN bond of the oxacarbenium ion bond to reduce
the nucleophile-electrophile distance. Finally, a target Glu or Asp
stabilizes the N-ribose, E461 stabilizes the target Arg which attacks
the oxacarbenium ion. Several residues hold the active site in place
including: S415 which H-bonds to E463; T416, which stiffens the
active site through H-bonds to a nearby b-sheet and S417, which
orients the ARTT loop and E461. Also, Y345 stabilizes E463.
Other potential active site residues include T346, E412 and F426.
EFV toxin expression in yeast, driven by the CUP1 promoter,
shows cell death in the presence of the wild-type toxin. We
observed dramatic restoration growth with the E461A and E463A
mutants and near-complete growth restoration with the E461A/
E463A double mutant (Figure 8C). The wildtype growth-defective
phenotype clearly shows EFV toxin toxicity. Substitutions to E461
and E463 confirm that this toxicity is because of EFV toxin ADP-
ribosyltransferase activity.
P. luminescens TccC5: An ADPRT associated with a toxin
complex
TccC5 (UniProt Q7N7Y7) is an ADPRT from P. luminescens
TT01 that we previously suggested as an ADPRT toxin [4], which
has gained significant attention recently [53]. Is distinct from the
recently reported Photox [56], but a close relative also exists in the
W14 strain.
TccC5 is 938-residue, 105 kDa protein and has four domains:
domain I (,1–341), domain II (,342–675), domain III (,676–
738) and domain IV (,739–938) (Figures 4E and 5E). This toxin is
non-classically secreted. Fold-recognition matches to TccC5 are to
various tandem seven-bladed b-propellers, including the actin-
interacting protein (PDB 1NR0; J3D-jury=71) and the Sro7
exocytosis regulator (PDB 2OAJ, a high-confidence LOMETS
match). These proteins are WD40 repeat-containing proteins
(SCOP b.69.4, CATH 2.130.10.10). Also, we found matches to
several tandem seven-bladed b-propeller xyloglucanase structures
(PDB IDs 3A0F, 2EBS, 2CN2; SCOP b.69.13; CATH
2.130.10.140) that hydrolyze polysaccharides.
Fold recognition on domain I, a hard target, produces matches
to various b-propellers such as bc-dimer of the heterotrimeric G-
protein transducin (PDB 1TBG, LOMETS high-confidence
match), oxidoreductases (PDB 1FWX, J3d-jury=123), outer surface
protein OspA (PDB 1FJ1, J3d-jury=83, LOMETS high-confidence
match to 2FJK), Tyr-Val-Thr-Asn (YVTN) domain from an
Figure 4. Toxin domain combinations. Domain combinations in the new ADPRT toxins based on DOMAC, Ginzu and sliding-window fold
recognition data. Mainly a-helix (green oval), mainly b-sheet (blue rectangle), a/b or a+b alpha-beta mixtures (orange), mainly loop or disordered
(grey). We mark secretion signal peptides with a green line. (A) Chelt (B) Certhrax (C) Mav toxin (D) EFV toxin (E) TccC5 (F) Vis.
doi:10.1371/journal.pcbi.1001029.g004
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LOMETS match), lyases (e.g., streptogramin B lyase, PDB 2QC5,
a LOMETS high-confidence match; and virginiamycin B lyase,
PDB 2Z2P, J3d-jury=51), among others. Function prediction
suggests domain I contains two YD repeats possibly involved in
binding carbohydrates and heparin. Also, domain I contains a
lipocalin pattern, hinting at a connection to small-molecule
transporters.
Fold recognition on domain II, also a hard target, shows there
may be a second b-propeller after the first. Matches are to various
b-propellers including OspA, YVTN from an archaeal surface
layer protein and the extracellular domain of LDL receptor (PDB
1N7D, a high-confidence LOMETS match), among others. The
C-terminal end of domain II appears to have recombination hot
spot (Rhs) repeats employed in other secreted bacterial insecticidal
toxins and eukaryotic intercellular signalling proteins, and often
involved in ligand binding. Rhs suggests horizontal transfer; it is
related to YD repeats and also often contains VgrG, a type VI
secretion protein. b-propellers are structurally conserved but
functionally diverse, so it is difficult to pinpoint exact functions for
domains I and II. While the exact role of these domains is unclear,
a likely role is gaining cell entry. Domain III seems helical with
unknown function.
TccC5 domain IV best matches SpvB but identity is only 25%
over the toxin core, making TccC5 among the most novel toxins
discussed here. Fold recognition results suggest that TccC5 is
similar to C3bot2 (PDB 1R45, J3d-jury=92) throughout the
catalytic domain. Recently, Lang et al. identified the cellular
target as RhoA Q63 [53].
We propose a likely mode of NAD
+ binding, target binding and
ADP-ribosylation based on alignment data and our modeling
experiments. TccC5 binds NAD
+ through hydrogen bonds,
hydrophobic interactions and aromatic interactions (Figure 6E,
Figure S4 in Text S1, Table 3). We propose these H-bonds: T777
binds to A-ribose, N742 and R746 bind to A-phosphate, R774
binds to A- or N-phosphate, R829 may bind N-phosphate, T735
and E886 bind to N-ribose and V775 binds to nicotinamide.
Active site residue F819 in the flexible PN loop locks the
nicotinamide in the enzyme cleft during the reaction. TccC5
recognizes RhoA using the region B active site loop (,748–751),
the PN loop (,812–828) and the ARTT loop (,861–885)
(Table 4). The ARTT loop might plastically rearrange between
the in and out conformation during this process. Compared to
SpvB, TccC5 has several key differences that may influence
targeting including: a 30 amino acid deletion in region B between
I750 and T751, an eight-residue insertion in the PN loop (F819–
S826) and a 32-residue insertion in the ARTT loop between A854
and E885. Other variations include a five-residue insertion
between I779 and K783 and two deletions that follow the ARTT
loop, namely, three residues between R901 and H902 and two
residues between I914 and K915. We propose the reaction follows
an SN1 alleviated-strain mechanism (Figure 7). First, E886 H-
bonds to the N-ribose while phosphate electrostatic interactions
hold the NAD
+ in a conformation that favors oxacarbenium ion
formation. The reaction’s progress is unclear. S738 might induce a
rotation about the O5D-PN bond of the oxacarbenium ion to
reduce the nucleophile-electrophile distance. A RhoA Glu or Asp
likely stabilizes N-ribose, TccC5 Q884 likely stabilizes RhoA Asp,
and finally RhoA Q63 attacks the oxacarbenium ion. Several
residues hold the active site in place including: S809, which H-
bonds to E886; T810, which stiffens the active site through H-
bonding to a nearby b-sheet and S811, which orients the ARTT
loop and Q884. Also, Y734 stabilizes E886.
Co-occurrence, neighbourhood, gene fusion and recent evi-
dence [53], suggest that TccC5 exists as part of a toxin complex
with the TcdA1 toxin and TcdB2 potentiator. Full activity
depends on these partners [76].
TccC5 expression in yeast, driven by the CUP1 promoter,
shows cell death in the presence of the wild-type toxin. We
observed mild growth restoration with the Q884A mutant,
dramatic growth restoration with the E886A mutant and near-
complete growth restoration with the Q884A/E886A double
mutant (Figure 8D). The wildtype growth-defective phenotype
clearly shows TccC5 toxicity. Substitutions to Q884 and E886
confirm that this toxicity is because of TccC5 ADP-ribosyltrans-
ferase activity.
V. splendidus Vis: A minimal ADPRT toxin
Vis (UniProt A3UNN4) is an ADPRT from a known pathogen,
V. splendidus 12B01, which causes vibriosis and afflicts oysters.
Similar proteins exist in Vibrio harveyi strains HY01 and BB120,
Photobacterium sp SKA34 and Photobacterium angustum S14. Vis toxin
is 30% identical to VopT from Vibrio parahaemolyticus. This single-
domain toxin has 249 residues and is 28 kDa. It harbors a
secretion signal peptide with a cleavage site between position 18
and 19 (Figures 4F and 5F). Fold recognition matches it to iota
toxin (PDB 1GIQ, J3D-jury=135). Vis entry into target cells is
unclear. It may travel through a transporter, be aided by other
pore-forming toxins or be directly released into the cytosol after V.
splendidus invasion.
We propose a likely mode of NAD
+ binding, target binding and
ADP-ribosylation based on alignment data and our modeling
experiments. NAD
+ binding (Figure 6F, Figure S4 in Text S1,
Table 3) likely involves these H-bonds: E137 binds to adenine,
W120 may bind to A-ribose, N76 and R80 bind to A-phosphate,
R117 binds to A- or N-phosphate, S68 and E191 bind to N-ribose
and G118 binds to nicotinamide. Active site residue F153 in the
flexible PN loop locks the nicotinamide in the enzyme cleft during
the reaction. Vis recognizes its target using the region B active site
loop (,82–91), the PN loop (,145–164) and the ARTT loop
(,180–190) (Table 4). Vis has a 24-residue deletion after the
region 1 Arg between K122 and L123. Also, and possibly affecting
targeting, it has a four-residue region B insertion between V89-
A92 and an eight-residue insertion in the PN loop between E148
and V155. The ARTT loop might plastically rearrange between
the in and out conformation during target recognition. The first
part of the ARTT loop is anchored between hydrophobic residues
I180 and L183 and is likely less flexible than the second part. This
second part, which hinges on S184 and E189, likely repositions
Y186 to interact with the target substrate. We propose the reaction
follows an SN1 alleviated-strain mechanism (Figure 7). First, E191
H-bonds to the N-ribose while phosphate electrostatic interactions
hold the NAD
+ in a conformation that favors oxacarbenium ion
formation. Then Y72 induces a rotation about O5D-PN bond of
the oxacarbenium ion that reduces the nucleophile-electrophile
distance. Finally, a target Glu or Asp stabilizes the N-ribose, E189
stabilizes the target Arg or Cys which attacks the oxacarbenium
ion. Several residues hold the active site in place including: S142,
which H-bonds to E191; T143, which stiffens the active site
through H-bonds to a nearby b-sheet and S144, which orients the
regarding embellishments to each domain’s core fold. We modeled the new ADPRT toxins using the I-TASSER server [121] and also MODELLER with
suitable templates. (A) Chelt (B) Certhrax (C) Mav toxin (D) EFV toxin (E) TccC5 (F) Vis. Quality scores are in Tables S2 and S3 in Text S1.
doi:10.1371/journal.pcbi.1001029.g005
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NAD
+ binding and glycohydrolase activity. F67 is another
conserved residue possibly involved in the reaction.
Vis toxin expression in yeast, driven by the CUP1 promoter,
shows cell death in the presence of the wild-type toxin. We
observed mild growth restoration with the E189A and E191A
Figure 6. Active site structure models with NAD
+ bound reveal important residues. NAD
+-bound active-site models, developed using
homology-based transfer. We used them to help reveal important residues and help understand plausible NAD
+-binding modes and reaction
mechanisms. These active-site models contain NAD
+ fit into the active site. We do not intend to imply specific loop conformations or the nature of
embellishments to the core fold. We built the models using MODELLER. Modeled active sites include: (A) Chelt (B) Certhrax (C) Mav toxin (D) EFV toxin
(E) TccC5 (F) Vis toxin. Quality scores are in Tables S2 and S3 in Text S1.
doi:10.1371/journal.pcbi.1001029.g006
Table 3. Residues important for NAD
+ binding and reaction.
Region Role
Iota toxin
comparison
(wt=100)
a Chelt Certhrax Mav toxin EFV toxin TccC5 Vis toxin
rearranges upon target
binding, stabilizes last E of
[QE]XE, may bind ‘‘vital N’’,
may reposition N-ribose ring
Y246 H62 Y279 Y686 Y345 Y734 F67
binds N-ribose T280 T687 T346 T735 S68
reaction step 2, rearranges
on target binding, aids
rotation of O5D-PN bond,
may ‘‘catch’’ oxacarbenium
ion before transfer
Y251A: 0; Y251F: 90 T71 Y284 Y691 F350 {S738, S739} Y72
Vital N binds A-phosphate N255 N288 N695 N354 N742 N76
may position ‘‘vital N’’ L258 L291 L698 L357 I745 L79
region B active
site loop
binds A-phosphate R43 R292 R699 R358 R746 R80
region 1 unclear Y294 Y24 Y340 V729 Y393 Y773 Y116
region 1 R binds A/N-phosphate R295A: 0; RRK: 1 R25 R341 R730 R394 R774 R117
region 1 R binds nicotinamide R296; (backbone H
bond)
A26 R342 G731 G395 V775 G118
binds A-ribose
b (2 residues) E301A: 0 S28 ,343–348 {S344} ,732–737
{T732, N733 }
,396–400 {N399,
E400}
,776–780;
{T777}
,119–123
{W120 }
binds adenine
c
(1–2 residues)
Y333? Y41? ,380–384 {Q382,
N384}
,748–752;
{E750}
,410–412 ,802–806 ,135–139
{E137}
Region 2 STS unclear F336 F77 Y385 F753 F413 Y807 F140
region 2 STS positions last E of [QE]XE
via H-bonds, stabilizes
oxacarbenium ion
S338A: 5 S79 S387 S755 S415 S809 S142
region 2 STS stiffens active site via H
bonds to nearby b-sheet
T339A: 20 T80 T388 T756 T416 T810 T143
region 2 STS orients ARTT loop and [QE]
of [QE]-X-E
S340A: 25 T81 S389 S757 S417 S811 S144
PN loop
(region E)
stacking interaction with
nicotinamide; mobile
F349A: 0; F349Y: 20 Y398 F768 F426 F819 F153
PN loop
(region E)
binds N-phosphate R352A: 0 R402 ,769–773 R437 R829 R166
ARTT loop Target recognition, may
reorient on ligand binding;
can bind last E of [QE]XE
Y375 H125 Y426 Y790 Y186
ARTT loop reaction step 3, substrate
specificity; (mobile)
E378A: 0; E378D: 0;
E378Q: 0
E128 Q429 E793 E461 Q884 E189
region 3 EXE binds N-ribose, reaction
step 1
E380A: 0; E380D: 0 E130 E431 E795 E463 E886 E191
Region 3 Unclear L382 L59 L433 L797 L465 L888 L193
aThese data apply to the homolog iota toxin and is rounded and reproduced from [33,122].
bPossible range given, followed by residues most likely involved; protein backbone H-bonding.
cPossible range given, followed by residues most likely involved.
doi:10.1371/journal.pcbi.1001029.t003
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double mutant (Figure 8E). The wildtype growth-defective
phenotype clearly suggests Vis toxicity. Substitutions to E189
and E191 confirm that this toxicity is because of Vis toxin ADP-
ribosyltransferase activity.
Conclusion
We have combined computer results with cell-based data to
improve toxin discovery and characterization. The six new toxins
described here are a significant addition to the list of known
ADPRTs. Interested readers may refer to Text S1 for further
discussion of trends in structure and function.
Future toxin discoveries will involve not only new entries to
public sequence and structure databases, but also updates to the
search pattern and perhaps even new folds. For example, Johnson
et al. recently showed the region 2 STS motif is not strictly needed
in an M. penetrans ADPRT [55]. Also, the PARP10 ADPRT does
not need the hallmark ‘‘catalytic Glu’’ because it uses a substrate-
assisted mechanism [77]. AexU from Aeromonas hydrophila [78,79]
may reveal a new ADP-ribosylation fold: our preliminary fold-
recognition tests suggest it does not adopt the typical ADPRT fold.
We must do much work to characterize the new toxins in vitro.
One challenge is developing a way to reliably overcome
expression, purification and solubility problems, which seem
typical in this family. If we can overcome these problems, we
may pinpoint structure details through X-ray crystallography in
cases where the toxin is amenable such techniques. Finding
intracellular targets will also aid in elucidating functional details.
Time-resolved crystallography, NMR spectroscopy and QM/MM
simulations may one day further reveal reaction dynamics [80].
Our efforts in cell-based characterization may involve more
complete in vivo characterization where we give purified toxin to
suitable target cells or model organisms. Applying knowledge of
these new toxins to improve human health and agricultural
production is a large-scale but worthwhile challenge.
Methods
Data mining: Searching for new ADPRT toxins
We used remote homolog detection strategies to find ADPRTs
within the set of all known sequences. Authors have reviewed
[81,82] and benchmarked [83] these strategies. Often the only way
to find remote homologs to a query sequence is through structure
links, so structure prediction and remote homolog detection often
rely on the same strategies. One effective strategy is to pair
structure prediction with matches to consensus patterns.
Russell et al. described the leading structure classification
databases [84]. We used the Structural Classification of Proteins
(SCOP) [85] and Class Architecture Topology Homology (CATH)
[86] databases. We extracted structure codes for the ADPRT
family from these databases for further searches. We used these
SCOP codes: d.166.1.1 (mART), d.166.1.2 (PARPs), d.166.1.3
(ARTs), d.166.1.4 (AvrPphF ORF2, a type III effector), d.166.1.5
(Tpt1/KptA), d.166.1.6 (BC2332-like) and d.166.1.7 (CC0527-
like). We used these CATH codes: 3.90.175.10 (DT Group
mART), 3.90.176.10 (C2- and C3-like mARTs, ARTs),
3.90.210.10 (CT-PT-like mARTs) and 3.90.182.10 (An-
thrax_PA-like). Teichmann et al. described several fold-recognition
databases [87]. To get a putative ADPRT toxin list, we searched
the structure classification codes for known ADPRTs against such
databases, including Gene3D [50] and SUPERFAMILY [51].
Data mining: Filtering hits
We filtered the resulting sequences for ADPRT toxins by
keeping only bacterial hits using NCBI taxon IDs, keeping only
hits from pathogens using gene ontology data and the GOLD
database [1], keeping only hits that tested positive for secretion
using SignalP 3.0 or Secretome P 2.0 and keeping only hits that
had the conserved ADPRT pattern using ScanProsite [88] with
this regular expression: [YFL]-R-X(27,60)-[YF]-X-S-T-[SQT]-
X(32,78)-[QE]-X-E. We formed this pattern strictly using known
3D structures in 3dLOGO and changing the resulting regular
expression to ensure that it captured known ADPRT toxins in
ScanProsite searches. We kept only hits with less than 50%
identity to a known toxin and further reduced the list by clustering
at the 50% identity level. We checked genetic context for
hydrolases using Entrez Gene [89] and removed sequences where
one was encoded nearby. (Ribosylhydrolases and ribosylglycohy-
drolases can de-ribosylate proteins. Hydrolases may suggest a
regulatory cycle or toxin-antitoxin selfish genetic entities [90].) We
selected several interesting examples to characterize and discuss.
We ranked the final toxin list in order of decreasing ISI Web of
Knowledge hits to the species name.
Multiple sequence alignment and phylogenetic analysis
For both the C2-C3-like toxins and the CT-PT-like toxins, we
aligned known and new toxins using 3D-Coffee [91], we visualized
the alignment using ESPript [92], we curated it to remove
positions with gaps using Phylogeny.fr [93] and converted it to
LOGO format using WebLOGO [94]. We produced a percent
identity matrix using ClustalX [95] to reveal the relationships
between the new and known ADPRT toxins.
We curated an alignment containing all ADPRT toxins by
removing positions with gaps to prepare it for phylogenetic
analysis by Bayesian inference with the MrBayes algorithm [96].
The likelihood model included six substitution types with
invariable and gamma rate variation across sites. Markov chain
Monte Carlo parameters included 10,000 generations, sampling a
tree every 10 generations. We discarded the first 250 trees
sampled.
Structure prediction: Fold recognition
Fisher reviewed fold recognition servers [97]. We sent the
putative ADPRT toxins to fold-recognition meta-servers including:
3D-jury [98], Pcons [99], Genesilico [100], LOMETS [101] and
Atome2 [102]. Sequences with top hits to ADPRT toxins or
ADPRT-related structures (e.g. ART, PARP, LF, etc.) remained
on the list. We recorded the J3D-jury and structure match for each
sequence. J3D-jury.=40 is usually correct, but ideally we like it to
be 100 or more for strong structure matches. We reassessed
sequences showing no match to ADPRT-like proteins by using
sliding-window fold–recognition (see structure prediction: domain
organization below). If no match to an ADPRT-related structure
Table 4. Toxin regions that interact with target(s).
Name
region B active
site loop
PN loop
(or a3 helix) ARTT loop
Chelt N/A 82–99 104–129
Certhrax 295–314 390–402 420–430
Mav toxin 701–705 758–768 784–794
EFV toxin 361–370 418–436 452–462
TccC5 748–751 812–828 861–885
Vis toxin 82–91 145–164 180–190
doi:10.1371/journal.pcbi.1001029.t004
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ScanProsite matches against fold-recognition results, and adjusted
them to ensure that we correctly identified the region 1 Arg, region
2 ‘‘STS’’ motif and region 3 ARTT motif.
Structure prediction: Domain organization
The CASP7 competition compared domain prediction tools
[103]. We present domain assignments and boundaries that often
differ from data in public domain databases or are unavailable.
We used top performer DOMAC (Accurate, Hybrid Protein
Domain Prediction Server). It uses both template-based and ab
initio methods and uses a PSI-BLAST generated profile to find
templates. For significant matches it uses MODELLER for
modeling and the protein domain parser (PDP) for domain
parsing. If it does not find matches, it relies on neural networks or
support vector machines (SVMs) [104]. We manually adjusted
Figure 7. Proposed mechanisms for the new toxins by homology-based transfer. The SN1 alleviated-strain mechanism, developed for Iota
toxin, is likely widely applicable throughout the CT group ADPRTs [34], given high structure similarity and consistent NAD
+ conformation in the active
site. Therefore, we use a 3DLOGO-based method to propose a homology-based mechanism for the new ADPRTs. First, the universally conserved
region 3 catalytic Glu (which H-bonds to the N-ribose) and the universally conserved region 1 Arg (which creates phosphate electrostatic interactions)
hold the NAD
+ in a conformation that favors oxacarbenium ion formation. Then, we invoke a Phe as well as the Tyr that induces a rotation of the
oxacarbenium ion about the O5D-PN bond of the N-ribose to relieve the strained NAD
+ conformation and help reduce the nucleophile-electrophile
distance. (Previous work has shown the Tyr to Phe substitution in Iota toxin is still active [34].) The electrophile and nucleophile may migrate by an
unknown mechanism that further reduces the distance between them. Finally, a target Glu or Asp stabilizes the N-ribose, the region 3 Glu or Gln
stabilizes the target Arg, Asn or Cys; Asn, Gln or Cys attacks the oxacarbenium ion, for region 3 QXE toxins, or an Arg attacks the oxacarbenium ion for
region 3 EXE toxins.
doi:10.1371/journal.pcbi.1001029.g007
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testing sliding windows of 50, 75, 100, 150, 200, 250, 300, 350 etc.
amino acids on the fold-recognition meta servers to identify
boundaries and fold type for the non-toxic domains. We mapped
PDB hits to SCOP and CATH codes and interpreted the results to
understand cell-entry strategies [105].
Structure prediction: Comparative modeling
Nayeem et al. compared modeling software [106]. Prime works
best for modeling in low sequence identity cases. But Modeller
[107] is widely used, updated often and freely available, so we
chose it for our work. For each candidate ADPRT, we used the
alignments in Figures S1 and S2 in Text S1 and 3D-jury to select a
suitable input alignment of the new toxin against a known
template. We inspected the input alignments to ensure that we had
properly aligned regions B, 1, 2 and 3.
We modeled NAD
+-bound structures using MODELLER and
alignments to an NAD
+-bound template: C3bot1 (PDB 2A9K)
[108], Iota toxin (PDB 1GIQ) [33], SpvB (PDB 2GWL) [109],
EDIN-B (PDB 1OJZ) [110], CdtA (PDB 2WN7) [111], Art2.2
(PDB 1OG3) [112], Vip2 (PDB 1QS2) [39] and cholera toxin
(PDB 2A5F) [113]. Except for Chelt, we used all templates to find
invariant features between the resulting models and interpret the
new toxins based on consistent NAD
+-binding patterns.
We modeled full-length ADPRT structures using I-TASSER,
the top-ranked program for fully-automated structure prediction
in CASP7. It combines folds and supersecondary structures
selected from the PDB with ab initio loop models. These elements
are reassembled and refined to produce the final model. When I-
TASSER failed to produce a result matching the sliding-window
fold recognition data (four cases), we selected suitable templates
from this fold recognition data. We docked the templates using
HADDOCK [114] and used them as MODELLER input. Where
appropriate, we used VTFM and MD to optimize the models and
repeated the modeling cycle at least two times to achieve an
adequate objective function (.1610
6). We refined loops auto-
matically after model building and ranked them by Discrete
Optimized Protein Energy (DOPE) statistical potentials to find the
top model. We visualized the models using PyMol.
Laskowski et al. reviewed model quality assessment programs
(MQAPs) [115]. We assessed the ADPRT models using MetaM-
QAPII, a meta-server that considers results from VERIFY3D,
PROSA, BALA, ANOLEA, PROVE, TUNE, REFINER and
PROQRES [116]. We also gathered model data using MolProbity
[117].
Function prediction: NAD
+ binding
We assessed NAD
+ binding using crystal structures solved with
NAD
+ in the active site: C3bot1 (PDB 2A9K) [108], Iota toxin
(PDB 1GIQ) [33], SpvB (PDB 2GWL) [109], EDIN-B (PDB
1OJZ) [110], CdtA (PDB 2WN7) [111], Art2.2 (PDB 1OG3)
[112], Vip2 (PDB 1QS2) [39] and cholera toxin (PDB 2A5F)
[113]. We used LigPlot [118] on the PDBsum server [119]) to
visualize the usual interactions in ADPRT NAD
+ binding. We
used the 3dLOGO [120] software to reveal equivalent positions in
these structures. We used conserved residues from the alignment
involved in typical NAD
+ binding interactions in the known
ADPRTs to identify the equivalent residues in the new ADPRTs.
We also analyzed our NAD
+-bound models and compared the
ADPRTs modeled directly against the NAD
+-bound templates
using Modeller [107].
Function prediction: Reaction mechanism
We developed the ADPRT toxin reaction mechanism for the
new toxins using the SN1 alleviated-strain model, first proposed by
Tsuge et al., that many believe is widely relevant to the entire
Figure 8. Growth-defective phenotype of yeast expressing the new ADP-ribosyltransferases. Growth of S. cerevisiae expressing WT or
mutant toxin with substitutions to catalytic residues. The CUP1 copper-inducible promoter drove toxin expression. (A) Catalytic domain of Chelt WT
(black), E128A (red), E130A (dark blue) and E128A/E130A (light blue). (B) Certhrax WT (black), Q429A (red), E431A (dark blue) and Q429A/E431A (light
blue). (C) EFV toxin WT (black), E461A (red), E463A (dark blue) and E461A/E463A (light blue). (D) TccC5 WT (black), Q884A (red), E886A (dark blue) and
Q884A/E886A (light blue). (E) Vis toxin WT (black), E189A (red), E191A (dark blue) and E189A/E191A (light blue). Error bars show the SD of eight
repeats.
doi:10.1371/journal.pcbi.1001029.g008
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+ binding we used 3DLOGO [120] to
reveal equivalent positions in these structures: C3bot1 (PDB
2A9K), Iota toxin (PDB 1GIQ), SpvB (PDB 2GWL), EDIN-B
(PDB 1OJZ), Art2.2 (PDB 1OG3), Vip2 (PDB 1QS2) and cholera
toxin (PDB 2A5F). We also matched residues involved in the iota
toxin mechanism to residues in SpvB, EDIN-B and C3bot1 and to
the new toxins using 3D-jury results. We exploited conservation of
the hallmark catalytic Glu for step 1, a conserved aromatic (usually
Tyr, but sometimes Phe) for step 2 and the secondary Glu or Gln
for step 3. We also used the rule that region 3 [QE]XE pattern
appears as EXE in ADPRTs that ribosylate Arg and as QXE in
ADPRTs that ribosylate Asn, Gln or Cys.
Cell-based validation
We cultured Saccharomyces cerevisiae strain W303 (MATa, his3,
ade2, leu2, trp1, ura3, can1) on yeast-peptone-dextrose or synthetic
dextrose (SD) drop-out medium. We performed the yeast growth-
defective phenotypic test and quantified growth as previously
described [48].
Supporting Information
Text S1 Supplementary discussion, figures, tables and data.
Found at: doi:10.1371/journal.pcbi.1001029.s001 (4.63 MB PDF)
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